Diazepine and diazocane compounds as MC4 agonists

Details for Australian Patent Application No. 2009278838 (hide)

Owner Pfizer Limited

Inventors Andrews, Mark David; Barber, Christopher Gordon

Agent Shelston IP

Pub. Number AU-A-2009278838

PCT Pub. Number WO2010/015972

Priority 61/086,530 06.08.08 US

Filing date 30 July 2009

Wipo publication date 11 February 2010

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/015972 Priority application(s): WO2010/015972

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009278841-A pipe with integral male and female ends, a joint made using the same pipe, and processes of making the pipe and the joint

2009278834-Partial discharge monitoring method and system